OFBiz

Single-Use Bioreactors Market Outlook: Trends and Predictions for the Next Decade

_‹ Previous Topic Next Topic _›

Classic

List

Threaded

1 message

HealthInsights

Single-Use Bioreactors Market Outlook: Trends and Predictions for the Next Decade

Single-Use Bioreactors Market Outlook, Scope & Overview:

Industry reports indicate that the global single-use bioreactors market was valued at USD 3,872.40 million in 2023 and is projected to reach USD 13,784.83 million by 2031, growing at a CAGR of 17.2% over the forecast period 2024-2031.

Technological Advancements to Drive Growth of Global Single-Use Bioreactors Market

The adoption of single-use bioreactors (SUBs) will continue to influence global market revenues. Biopharmaceutical companies and research institutions are increasingly utilizing SUBs to enhance production efficiency, reduce contamination risks, and lower manufacturing costs.

As a product segment, SUBs currently hold a significant share of the global bioprocessing market. This segment is anticipated to grow at a year-over-year rate of 17.2% in 2024 over 2023 and reach USD 13,784.83 million in revenues by 2031. The increasing demand for biologics and biosimilars, coupled with advancements in cell culture technologies, is expected to drive market growth.

Single-Use Bioreactors – Market Dynamics

Drivers:

Single-use bioreactors are witnessing significant growth in the global market due to their ability to provide flexibility, scalability, and cost-effectiveness in biopharmaceutical production. The growing focus on reducing the risk of cross-contamination, the need for efficient process development, and the increasing adoption of disposable technologies in bioprocessing are key factors driving the adoption of SUBs worldwide. Additionally, the rising demand for personalized medicine and regenerative therapies is further propelling market growth.

Restraints:

Despite the growth potential, challenges such as high initial costs, concerns about the environmental impact of disposable systems, and the need for robust validation processes are hindering the widespread adoption of single-use bioreactors. Moreover, the limitations in handling large-scale production and the technical challenges associated with integrating SUBs into existing bioprocessing workflows pose additional challenges to market expansion.

Single-Use Bioreactors – Market Outlook

The proven benefits of single-use bioreactors in enhancing production efficiency, reducing operational costs, and improving process control have contributed to the market's growth. SUBs are expected to witness increased adoption across major biopharmaceutical markets, including North America, Europe, and Asia Pacific, driven by advancements in biotechnology and the growing focus on bioprocess optimization.

Global Single-Use Bioreactors Market

The rise in demand for single-use bioreactors in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global SUB market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of single-use bioreactors, supported by favorable regulatory frameworks and increasing investments in biopharmaceutical manufacturing.

Key Players in the Single-Use Bioreactors Market

Leading companies in the single-use bioreactors market include Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, and Merck KGaA. These companies are at the forefront of developing and commercializing advanced single-use bioreactor systems for various bioprocessing applications, including cell culture, fermentation, and vaccine production.

In conclusion, the global single-use bioreactors market is poised for substantial growth over the forecast period, driven by technological advancements, increasing demand for biologics, and the expanding adoption of disposable bioprocessing solutions in biopharmaceutical production.